Hamburg - Delayed Quote EUR
Heidelberg Pharma AG (HPHA.HM)
As of 8:16 AM GMT+1. Market Open.
Key Executives
Key Executives Information Not Available
Heidelberg Pharma AG
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Heidelberg Pharma AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
October 10, 2024 at 6:00 AM UTC
Heidelberg Pharma AG Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
PRLD Prelude Therapeutics Incorporated
1.2700
0.00%
RAPP Rapport Therapeutics, Inc.
26.90
0.00%
IMAB I-Mab
1.0750
-0.46%
2269.HK WuXi Biologics (Cayman) Inc.
17.120
-2.39%
RAPT RAPT Therapeutics, Inc.
3.1150
+0.48%
MRSN Mersana Therapeutics, Inc.
2.5400
-0.39%
TNGX Tango Therapeutics, Inc.
2.8300
0.00%
GLUE Monte Rosa Therapeutics, Inc.
9.79
+2.73%
CCCC C4 Therapeutics, Inc.
6.05
+0.23%
INCY Incyte Corporation
83.08
+0.90%